Learn more about this innovative therapy at a complimentary seminar on Thursday, December 8, 2022
The NeuroHealth Center specializing in Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS®) – a pain-free, drug-free, noninvasive procedure that can change the life of children and adults with Autism Spectrum Disorder (ASD) – is now open in Hackettstown, New Jersey. The center is inspired by Frank and Mary Plut, who witnessed the impact PrTMS had on their young son, Frankie, and are passionate about helping other families affected by ASD.
PrTMS transformed Frankie – seen here with his parents Frank and Mary – from a non-verbal, non-social youngster to an outgoing, verbal and mainstreamed 8th grader.
“When Frankie was eight months old, we knew something wasn’t right,” Frank shares. “At 18 months old, he was diagnosed with autism. Nonverbal – with multiple daily meltdowns and dangerous behaviors – we tried everything.”
Desperate to help their child, Frank and Mary learned about PrTMS, a life-changing therapy that gave them hope … and results.
“We took Frankie to see Kevin T. Murphy, MD, inventor of PrTMS, in California, the only location administering this unique therapy at the time,” Frank explains. “Frankie went through a series of daily weekday treatments for several weeks.”
Specially designed to meet the individual needs of each patient, PrTMS gently delivers personalized, repetitive magnetic pulses to five or six targeted areas of the brain. During each treatment session, an electromagnetic coil is placed near the patient’s scalp at these targeted locations on the head. The electromagnetic field painlessly stimulates the brain’s neurons, rebuilding the abnormal cranial minicolumns in ASD patients and improving the brain’s executive functioning.
Each treatment takes approximately 20 minutes. Most patients are treated five times a week – Monday through Friday – for six to 12 weeks. An EEG is taken every five days to determine progress and the treatment’s path forward. Within the first two weeks, it can be determined if the patient is responding to the therapy. If the patient responds positively, continued treatment is recommended. If the patient is not responding in the first two weeks, the recommendation will be to discontinue treatment.
Thanks to PrTMS, today Frankie is a mainstreamed 8th grade student.
“Frankie is completely conversant,” Frank continues. “He reads and writes, is social, no longer has meltdowns, narrates his own YouTube channel … and no longer toe walks.”
One day, Frankie wants to work with his dad at the NeuroHealth Center “because I want to help people…”
“The difference between the child we took to California and the one we returned home with was night and day. On the plane to California, Frankie was just making baby babble. On the way back, he was looking out the window saying ‘Goodbye California! See you soon.’ This was a kid who was nonverbal 30 days prior to the treatment, and now he is speaking and his feet are flat on the ground rather than walking on his toes.”
In addition to helping children like Frankie by potentially transforming non-verbal patients into verbal children, reducing meltdowns and diminishing toe walking, PrTMS may change patients’ lives by:
- Reducing destructive behaviors
- Promoting social interactions and eye contact
- Fostering adaptability to smoothly transition from one activity to another
- Decreasing anxiety and enhancing stress coping mechanisms
- Improving overall mood and reducing depression
- Promoting sleep
- Advancing memory and mental clarity
- Increasing attention span and ability to focus
Each child’s brain is unique, and the 30-day treatment window varies with each individual.
PrTMS is FDA approved to treat Major Depressive Disorder and may be used Off Label (not covered by insurance) to treat autism, anxiety disorder, traumatic brain Injury, post-traumatic stress disorder, attention deficit hyperactive disorder, stroke, dementia, Parkinson’s, obsessive-compulsive disorder and other neurological disorders.
The NeuroHealth Center is hosting a free seminar explaining PrTMS treatment for autism on Thursday, December 8, from 6:00 – 9:00 pm at the Sheraton Parsippany Hotel, 199 Smith Road in Parsippany, NJ. The public is invited to meet Dr. Murphy who will explain how this protocol is successfully treating autism.
You can also learn more about the NeuroHealth Center and PrTMS at neurohealthcenters.org. You may also email contact@NeuroHealthCenters.org or call 973.453.5423.